Torys acts for a wide range of healthcare clients in the United States and Canada. We advise on emerging developments in healthcare legislation, professional and institutional obligations, reimbursement regulations, and service contracts with providers, facilities and joint ventures, and a wide range of litigation issues. We provide advice relating to mergers and acquisitions, tax and institutional issues, and we represent healthcare clients in litigation and dispute resolution, class actions and constitutional, administrative and regulatory and professional negligence and discipline matters. Our healthcare clients include hospitals; managed care companies; practice management companies; clinics; physicians and physician groups; providers of rehabilitation services; medical instrumentation companies; and private and institutional investors, lenders and venture capital funds that invest in and service the healthcare community.
We have significant litigation experience in the healthcare area, and have acted on cases dealing with disclosure of medical records, consent to treatment, prosecution of directors for professional misconduct, medical privileges and blood transfusion (including the first blood transfusion case to proceed to trial in Canada). Torys is counsel for the Canadian Red Cross Society in two class actions concerning alleged transfusions of associated Hepatitis C. We have significant experience with issues involved in the restructuring, merger and closure of hospitals. Torys represented the Ontario Health Services Restructuring Commission defending litigation challenging its decisions on Ontario hospital closings and amalgamations.
Torys has experience in advising on the corporate and human resources issues associated with the restructuring and closure of hospitals and other healthcare facilities, as well as directors' responsibilities in the management of healthcare organizations. We also advise health insurance organizations, government and other healthcare participants on non-pension benefit plans and drug plans.